Certara to Participate in Upcoming Investor Conferences

RADNOR, Pa., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:

• TD Cowen 46^th Annual Health Care Conference
  Date and Time: Tuesday, March 3^rd, 2026, at 3:10PM ET

• Leerink Global Healthcare Conference
  Date and Time: Monday, March 9^th, 2026, at 8:00AM ET

• Barclays 28^th Annual Global Healthcare Conference
  Date and Time: Tuesday, March 10^th, 2026, at 1:00PM ET

Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.

About Certara
Certara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,600 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Visit us at www.certara.com.  

Investor Relations Contact:
David Deuchler
Gilmartin Group
[email protected]

Media Contact:
Alyssa Horowitz
[email protected]

You May Also Be Interested In

• Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluat
• JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija‘ unaudited interim report for the first six months of 2026
• New Research Released by Corporate Visions Finds the Most Common Sales Pursuit Strategy Is Also the Least Effective